Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
NCT01585155
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Pediatric Ulcerative Colitis
Interventions
DRUG:
TA-650
Sponsor
Tanabe Pharma Corporation